Study of Cancer Germline Test Results From 10,000 Patients Highlights Utility of NGS Panels | GenomeWeb

NEW YORK (GenomeWeb) – Analyzing hereditary cancer gene panel test results for the first 10,000 patients referred to its laboratory, researchers at GeneDx and their collaborators have found that almost one in 10 patients harbored either a pathogenic or a likely pathogenic variant.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.